Solid Biosciences Inc.SLDB
Price (close)
$7.48
Market cap
$786.3M
P/E
—
Revenue (TTM)
—
Net income
-$207.1M
Dividend yield
—
1-year total return
26.4%
Net margin
—
Revenue growth
—
Debt / equity
—
What Solid Biosciences Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $0 | $13.6M | $8.1M | — | — | — |
| Net income | -$88.3M | -$72.2M | -$86.0M | -$96.0M | -$124.7M | -$174.3M |
| Free cash flow | -$57.5M | -$79.0M | -$101.0M | -$95.7M | -$100.7M | -$157.4M |
More on SLDB.
- Solid Biosciences Inc. summary
- Solid Biosciences Inc. financial statements
- Solid Biosciences Inc. key metrics
- Solid Biosciences Inc. health scores and style box
- Solid Biosciences Inc. earnings
- Solid Biosciences Inc. dividends
- Solid Biosciences Inc. valuation
- Solid Biosciences Inc. ownership and insiders
- Solid Biosciences Inc. peers
Figures from Solid Biosciences Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.